NovaBay Shareholder Information .... Investor

New Post Public Reply Private Reply Replies (0) Message Board
crookedneck

NovaBay Shareholder Information ....

Investor Overview

NovaBay Pharmaceuticals is a clinical stage biotechnology company focused on developing its proprietary and patented topical Aganocide® compounds, which are novel, synthetic anti-infective product candidates with equivalent activity to the active antimicrobial molecules generated within white blood cells. NovaBay's topical Aganocide compounds are being developed to treat and prevent a wide range of infections without causing bacterial resistance. NovaBay has internal development programs aimed at addressing hospital infections, chronic non-healing wounds, UCBE and onychomycosis.

NovaBay has entered into and recently expanded an agreement with Galderma S.A. to develop and commercialize Aganocide compounds in acne, impetigo and other dermatological indications.

Transfer Agent

The transfer agent and registrar for our common stock is Computershare Trust Company, N.A. with the following contact information:

For standard US postal mail
Computershare Trust Company, N.A.  
Po Box 43070
Providence, RI 02940-3070

For overnight/express delivery
Computershare Trust Company, N.A.
250 Royall Street
Canton, MA 02021

For DWAC instructions provided to brokers
FAST Transfer Agent number – 50173

Telephone and Fax
Toll free in the US +1 800 962 4284
Telephone +1 303-262-0600
Fax +1 303-262-0700

Website
www.computershare.com

eMail inquiries
web.queries@computershare.com

Investor Relations contacts
Theresa Granados
(510) 899-8870 
Email Theresa

Events

May 18, 2011
Archive of Conference call Re: Results from Phase 2 Clinical Study for the Treatment of Adenoviral Conjunctivitis
 Click Here To Listen

September 21, 2010
Behzad Khosrovi, M.A., Ph.D. of NovaBay Interviewed on HealthRadio.net about Antibiotic Resistance 

July 21, 2010
Archive of Conference call Re: Impetigo Clinical Trial Results
 Click Here To Listen

July 10-14, 2010
Ron Najafi, NovaBay CEO, to be Plenary Speaker at Controlled Release Society (CRS) Annual Meeting

April 19, 2010
Archive of Conference call Re: CAUTI Trial Pipeline Update

 Click Here To Listen

March 25, 2010

Catheter-Associated Urinary Tract Infection Expert, David Stickler, Interviewed
 Click Here To Listen

February 09, 2010

NovaBay CEO Ron Najafi Presents at BIO CEO & Investor Conference
 Click Here To Listen

January 10, 2010

Founding Director of UCLA's Urological Center and NovaBay SAB Member, Bernard Churchill, M.D., Interviewed
 Click Here to Listen

December 22, 2009

World-Renowned Biofilm Expert and NovaBay SAB Member, William Costerton, Ph.D., Interviewed
 Click Here to Listen

March 25, 2009

NovaBay and Galderma enter into Global Agreement to Develop and Commercialize NovaBay’s Novel Aganocide Drugs for Major Dermatological Conditions 
 View this webcast Wednesday, March 25, 2009 at 8:00AM PT

August 7, 2008

NovaBay Pharmaceuticals, Inc. Featured on KGO-TV San Francisco
  The video can be viewed here

Corporate Governance

NovaBay is committed to good governance and business practices. High standards of corporate governance are a priority at NovaBay. The Board and management team believe that commitment to excellence and integrity is essential to the long-term success of the Company and to sustaining strong stakeholder relationships. NovaBay uses a variety of policies, programs and practices to manage corporate governance. 

Code of Business Conduct and Ethics 
Audit Committee Charter 
Whistleblower Policy 
Corporate Governance Guidelines 
Compensation Committee Charter 
Nomination and Corporate Governance Committee Charter  
Composition of Board Committees

Novabay Pharmaceuticals (NBY) Stock Research Links

NBY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Major Donations Boost Mesothelioma Research Funding

Updated Category News Views 126

Significant Boosts in Mesothelioma Support November's chill didn't slow down major support for mesothelioma initiatives. On October 22, 2026, during the grand setting of the Foundation's 2026 International Symposium on Malignant Mesothelioma in The Woodlands, Texas, MesoCare.org and Danziger & De Llano, LLP stepped up big time. Their philanthropic moves weren't just about...

Continue Reading
Andersen's Window Revamp: Addressing Demand Surge

Updated Category News Views 53

Portfolio Boost: Adapting to Market Needs If you're sniffing around the windows business, there's a fresh breeze of innovation blowing from Andersen. They're not just sitting around drumming their fingers—they're rolling up their sleeves and fine-tuning their offerings. With half of homeowners swinging a hammer on renovations last year, the company sees an opportunity...

Continue Reading
ASUR's October Traffic Sees Mixed Results Across Regions

Updated Category News Views 77

A Patchwork of Gains and Losses Take a look at Grupo Aeroportuario del Sureste, S.A.B. de C.V. (NYSE: ASR), and you’ll see a mixed bag when it comes to October 2026’s passenger traffic. While some regions like Puerto Rico and Colombia took a step forward, others like Mexico and Costa Rica tripped up, resulting in an overall decline of 0.9% compared to last October....

Continue Reading
Tata Power Faces Enforcement Order for $650M Debt

Updated Category News Views 98

Tata's Troubles Escalate Grab a cup of coffee, folks, because this is one rollercoaster of a story that every investor needs to have on their radar. We're talking about Singapore courts coming down on Tata Power like a freight train, with enforcement orders that feel like a page out of a high-stakes drama. The Gavel Drops: What's Happening? The court in Singapore has...

Continue Reading
Silvercorp Navigates Q2 with Strategic Resilience

Updated Category News Views 113

Silvercorp's Q2: A Mixed Bag of Gains and Strains Coming in hot this November, Silvercorp swings between highs and lows for Q2 Fiscal 2027. They reported a not-too-shabby adjusted net income of $18.4 million—or $0.08 a pop per share. No one's throwing a parade for that, but it's stable sailing amidst some choppy waters. Safety Comes with a Price Safety upgrades have...

Continue Reading
2026 Midterms: Bond Market Shifts Investors Eye

Updated Category News Views 54

Reassessing Bonds Post-2026 Midterms When the election circus packs up its tents, investors like us are left standing in the wreckage, trying to figure out what's next for our portfolios. That's just where One Oak Capital Management's latest research fits into our jigsaw—exploring how the political winds can ripple through the layers of the bond market. Federal...

Continue Reading
WIC 2026: Global Connectivity and Cyber Futures

Updated Category News Views 117

Connectivity Takes Center Stage in Wuzhen When you throw 1,800 movers and shakers into a room focused on the future of the internet, sparks are gonna fly. That's exactly what's going down at the 2026 World Internet Conference in Wuzhen, China. Brass tacks: this ain't just another snooze-fest. The theme this year screams significance—'Open Source and Openness, Joined...

Continue Reading
Alley Cat Allies Sues Lincolnton Over Cat Shooting

Updated Category News Views 354

Legal Battle Over a Cat's Tragic End Picture the scene: a peaceful neighborhood in Lincolnton, Georgia, where the serenity was ripped apart by the shocking shooting of Piper the cat. This isn't some playground scuffle, my friends. Alley Cat Allies has taken this tragedy to the courts, filing a lawsuit against the city and its mayor. What's at stake here isn't just legal...

Continue Reading
TELUS Boosts Board with Strategic Executive Appointments

Updated Category News Views 69

New Faces on the TELUS Board: Shaping the Future Alright, investors, here's the scoop straight from the trenches: TELUS (TSX:TU) is shaking things up at the top. Marc Allera and Bill Thomas are stepping into the fray as the newest members of the board, effective January 1, 2027. If you're not familiar with these names, it's time to tune in because they've got the chops to...

Continue Reading
Ravens & MedStar Host Cancer Patients' Tailgate Bash

Updated Category News Views 45

If you thought a hospital could never host a touchdown of a tailgate, think again. The Baltimore Ravens and MedStar Health joined forces to throw the second annual Ravens Crucial Catch Tailgate Experience. This ain't your average pre-game party, folks—it's a blowout right in the hospital for cancer patients and their families, serving up a hefty dose of fun, food, and,...

Continue Reading

Top 5 Most Recently Viewed Articles

SelectQuote, Inc. Announces Impressive Q2 Fiscal Results

Updated Category News Views 117

Record Quarter for SelectQuote, Inc. SelectQuote, Inc. (NYSE: SLQT) reported significant growth in its consolidated revenue for the second quarter of fiscal year 2025, reaching $481.1 million. This reflects a notable increase from $405.4 million in the same quarter of the prior year. Alongside revenue growth, the company achieved consolidated net income of $53.2 million,...

Continue Reading
Usbit Trading Center Unveils New Logo in Celebration of Growth

Updated Category News Views 137

Usbit Trading Center Celebrates Brand Evolution Usbit Trading Center has officially launched its new logo and visual identity, commemorating a significant milestone in its journey as a global digital asset trading platform. This thoughtful rebranding effort reinforces the company's core values of security, innovation, and accessibility, which are essential in a time when...

Continue Reading
Empowering Biotech Founders with Ignite Golden Tickets Initiative

Updated Category News Views 123

Empowering Biotech Founders with Ignite Golden Tickets Initiative $250,000 of Ignite Golden Tickets will provide opportunities for early-stage biotech founders to leverage LabCentral's lab space, shared resources, and community. LabCentral, a leading network of coworking labs designed to accelerate high-potential biotech startups, has launched its fifth annual Ignite...

Continue Reading
Bitcoin Sees Decline Amid Market Adjustments

Updated Category News Views 48

Bitcoin Pulls Back Bitcoin has seen a decline, falling below $63,000 as traders took profits following a recent rally. The cryptocurrency market is under pressure as investors adjust their positions after the price surge over the weekend. According to data from CoinGecko, Bitcoin dropped by 1.4% in just 24 hours. Other major cryptocurrencies, including ether, BNB from BNB...

Continue Reading
Silver Shines Brightly as Investment Opportunities Expand

Updated Category News Views 156

Silver's Surprising Rise in 2025 The financial landscape is witnessing a remarkable shift as the relentless rise of silver eclipses even gold and the S&P 500 in recent times. Traditionally seen as the overlooked sibling of precious metals, silver is undergoing a transformation that is catching the attention of investors everywhere. With an impressive rise of around 95%...

Continue Reading